Nabis Holdings, Inc. (OTC Pink: NABIF) (CSE: NAB) is a Canadian investment company, which primarily focuses on cannabis. U.S.-listed shares of the Canadian cannabis investment company surged 61.36%, during trading on Wednesday, October 2, 2019. Over the past month, U.S.-listed shares of Nabis Holdings have seen average daily volume of 206,009 shares. However, volume of 87,711 shares or dollar volume of $6,402, exchanged hands during trading on Wednesday.
Shares of the cannabis investment firm surged, after the company provided a shareholder update and released third quarter 2019 financial results. During Q3, Nabis Holdings expanded its U.S. footprint, specifically in Arizona, California, and Washington. In Arizona, the company acquired a 44,000 sq. ft. cultivation and production facility in Camp Verde, and entered into a definitive agreement to acquire a licensed medical cannabis business based out of Phoenix. In California, Nabis Holdings signed a definitive acquisition agreement for Desert’s Finest, a 6,000 sq. ft. dispensary in Desert Hot Springs, CA. Lastly, Nabis Holdings acquired an established extraction and production facility in Washington state.
Outside of its U.S. expansion, Nabis continued to focus on growing its portfolio of cannabis brands. Specifically, the company launched BIS, a CBD-focused brand. Furthermore, the company signed a strategic alliance with CannaKorp, Inc., to be an authorized manufacturer and distributor of its Wisp Vaporizing System’s Wisp Pods in Arizona. Nabis Holdings also acquired a 49% stake in Cannova Medical, an Israeli company focused on developing sublingual strips for an alternative way to consume cannabis.
Turning to third quarter 2019 financial results, Nabis reported a net loss of C$5.2 million, compared to a net loss of C$0.06 million during the third quarter 2018. As of the end of July 2019, the company noted total assets of C$44.6 million, which included cash and cash equivalents of C$20.3 million and working capital of C$19.5 million.
Nabis Holdings, Inc. Press Release:
VANCOUVER, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (CSE:NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis™” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, reported its financial results for the third quarter ended July 31, 2019. All financial information is provided in Canadian dollars unless otherwise indicated.
“We continue to make progress on our strategic plan by diligently working on and closing acquisitions in Arizona, California, Michigan and Washington. In Arizona, we successfully acquired a 44,000 sq ft cultivation, fulfillment and production facility to serve as our hub of operations. With a definitive agreement signed on a Phoenix, AZ based dispensary along with a manufacturing & supplier agreement in AZ for WISP, a unique vaporizing solution, we are excited about the opportunity for Nabis in this state,” said Shay Shnet, CEO and Director of Nabis.
“We are pleased to report a strong balance sheet with a cash balance that will fund us through our previously announced acquisitions. As we focus on driving our business forward, yesterday we announced a strategic new hire to strengthen our management team. Nicole Rusaw joins Nabis as our Chief Financial Officer as an experienced public company leader with a proven track record. With our enhanced leadership at the helm, we look forward to reaching many milestones performance on our strategic initiatives,” concluded Mr. Shnet.
Third Quarter 2019 Highlights and Subsequent Events
Expanded U.S. Footprint
- Arizona: In September, the Company acquired a 44,000 sq. ft. cultivation, fulfillment and production facility located in Camp Verde, Arizona near Phoenix. This facility will serve as the hub of Nabis’ operations. In August, the Company signed a definitive agreement to acquire a licensed medical marijuana business including a Phoenix dispensary.
- California: In June, the Company signed a definitive agreement to acquire Desert’s Finest, a 6,000 sq ft dispensary located in Desert Hot Springs, California. Nabis announced yesterday improved terms to the acquisition agreement; press release can be found here.
- Washington: In May, the Company purchased an established extraction and production facility.
Growing Brand Portfolio
- Launched BIS (Be In Synergy), a new CBD exclusive brand created and owned by Nabis.
- Announced strategic alliance with CannaKorp, Inc. for its Wisp Vaporizing System as an authorized manufacturer and supplier of Wisp Pods in Arizona.
- Acquired a 49% stake in Cannova Medical, an Israeli based company and developer of the sublingual strip, an alternative method for cannabis consumption.
Experienced Leadership Team
- Appointed Nicole Rusaw as Chief Financial Officer, effective October 1, 2019.
- Announced industry veteran, Emmanuel Paul as an Independent Director in August 2019.
- In May, Nabis secured DTC Eligibility for its shares listed on the OTC, improving the trading process in the U.S.
Financial Results for the Third Quarter Ended July 31, 2019
Net loss for the third quarter of 2019 was $5.2 million compared to a net loss of $0.06 million in the third quarter of 2018.
Balance Sheet and Liquidity
As of July 31, 2019, the Company had total assets of $44.6 million, including cash and cash equivalents of $20.3 million and a working capital position of $19.5 million.
As of October 1, 2019, there were 109,604,435 shares of common stock outstanding.
About Nabis Holdings Inc.
Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical, one of the largest takeovers in the U.S. Cannabis space to date, the company has a proven track record in emerging markets to create significant shareholder value. The Company is focused on
For more information, please visit https://www.nabisholdings.com/.
All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The risks are without limitations: that the acquisitions will be completed by the Company or completed upon the terms disclosed; the price for cannabis and related products will remain consistent and the consumer demand remains strong; availability of financing to the Company to develop the retail locations; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.